US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Artiva Biotherapeutics, Inc.

10.93

-0.2100-1.89%

Post-market: 10.930.00000.00%19:30 EDT

Volume:199.42K

Turnover:2.21M

Market Cap:534.32M

PE:-3.41

High:11.60

Open:11.26

Low:10.76

Close:11.14

52wk High:14.53

52wk Low:2.22

Shares:48.89M

Float Shares:19.90M

Volume Ratio:0.63

T/O Rate:1.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.2084

EPS(LYR):-3.4309

ROE:-36.58%

ROA:-22.34%

PB:1.54

PE(LYR):-3.19

Loading ...

Overview Company News Filings

Artiva Biotherapeutics, Inc. (ARTV) Receives a Buy from Jefferies

Artiva Biotherapeutics Price Target Maintained With a $18.00/Share by Needham

Artiva Biotherapeutics Q4 EPS $(0.84) Misses $(0.83) Estimate

Benzinga Earnings

Artiva Biotherapeutics FY2025 net loss rises 28% to USD 83.87 million

Press Release: Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights

Artiva Biotherapeutics Files Initial Beneficial Ownership Statement for CFO Huston Thad Allen

Artiva Biotherapeutics Awards CFO Thad Huston 220,000 RSUs Under 2025 Inducement Plan

Press Release: Artiva Biotherapeutics Announces Appointment of Thad Huston as Chief Financial Officer and Award of Inducement Grant

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/ARTV/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ARTV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTV\",,,,,undefined,":{"symbol":"ARTV","market":"US","secType":"STK","nameCN":"Artiva Biotherapeutics, Inc.","latestPrice":10.93,"timestamp":1787342400000,"preClose":11.14,"halted":0,"volume":199424,"hourTrading":{"tag":"盘后","latestPrice":10.93,"preClose":10.93,"latestTime":"19:30 EDT","volume":1056,"amount":11537.2656,"timestamp":1787355006264,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.01885098743267512,"floatShares":19899500,"shares":48885777,"eps":-3.20842,"marketStatus":"Market Closed","change":-0.21,"latestTime":"08-21 16:00:00 EDT","open":11.26,"high":11.5995,"low":10.7601,"amount":2207925.408512,"amplitude":0.07535,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.20842,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1721361600000,"exchange":"NASDAQ","adjPreClose":11.14,"preHourTrading":{"tag":"盘前","latestPrice":11.14,"preClose":11.14,"latestTime":"09:19 EDT","volume":412,"amount":4642.280452,"timestamp":1787318352959,"change":0,"changeRate":0,"amplitude":0.000898},"postHourTrading":{"tag":"盘后","latestPrice":10.93,"preClose":10.93,"latestTime":"19:30 EDT","volume":1056,"amount":11537.2656,"timestamp":1787355006264,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6262510163768558,"impliedVol":0.3375,"impliedVolPercentile":0.3043},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTV\",,,,,undefined,":{"symbol":"ARTV","floatShares":19899500,"roa":"-22.34%","roe":"-36.58%","lyrEps":-3.430895,"volumeRatio":0.6262510163768558,"shares":48885777,"dividePrice":0,"high":11.5995,"amplitude":0.07535,"preClose":11.14,"low":10.7601,"week52Low":2.22,"pbRate":"1.54","week52High":14.53,"institutionHeld":0,"latestPrice":10.93,"eps":-3.20842,"divideRate":0,"volume":199424,"delay":0,"ttmEps":-3.20842,"open":11.26,"prevYearClose":4.29,"prevWeekClose":11.45,"prevMonthClose":10.1,"prevQuarterClose":9.7,"fiveDayClose":11.45,"twentyDayClose":10.03,"sixtyDayClose":7.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARTV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"ARTV","fiscalQuarterEnding":"2026/06","expectedEps":-0.64,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.63},{"market":"US","date":"2026-05-08","symbol":"ARTV","fiscalQuarterEnding":"2026/03","expectedEps":-0.88,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":-0.95},{"market":"US","date":"2026-03-10","symbol":"ARTV","fiscalQuarterEnding":"2025/12","expectedEps":-0.87,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"post","actualEps":-0.84},{"market":"US","date":"2025-11-12","symbol":"ARTV","fiscalQuarterEnding":"2025/09","expectedEps":-0.92,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.88},{"market":"US","date":"2025-08-06","symbol":"ARTV","fiscalQuarterEnding":"2025/06","expectedEps":-0.84,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.87}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARTV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARTV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1735617600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARTV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARTV","date":"2026-08-21","current":-3.406661,"percent":0.164063,"low":-11.820615,"twenty":-5.366075,"median":-1.692595,"eighty":-0.938902,"high":-0.499349,"avg":-3.236324,"sd":2.976381,"marketCap":544635947},"quantilePoints":[{"date":"2024-08-02","current":-10.391793,"twenty":-10.391793,"median":-10.391793,"eighty":-10.391793,"marketCap":269833291},{"date":"2024-08-09","current":-9.862789,"twenty":-10.391793,"median":-10.042112,"eighty":-9.943484,"marketCap":256097171},{"date":"2024-08-16","current":-10.185571,"twenty":-10.248334,"median":-10.131774,"eighty":-9.95245,"marketCap":264478532},{"date":"2024-08-23","current":-8.939273,"twenty":-10.248334,"median":-10.051078,"eighty":-9.342751,"marketCap":232117163},{"date":"2024-08-30","current":-8.088598,"twenty":-10.185571,"median":-9.943484,"eighty":-9.046867,"marketCap":263081639},{"date":"2024-09-06","current":-8.893463,"twenty":-10.142533,"median":-9.800025,"eighty":-8.930111,"marketCap":289259885},{"date":"2024-09-13","current":-8.019798,"twenty":-10.131774,"median":-9.459311,"eighty":-8.763533,"marketCap":260843926},{"date":"2024-09-20","current":-8.759053,"twenty":-10.07439,"median":-9.028935,"eighty":-8.450238,"marketCap":284888199},{"date":"2024-09-27","current":-9.946342,"twenty":-10.07439,"median":-9.323455,"eighty":-8.581333,"marketCap":323504758},{"date":"2024-10-04","current":-11.499524,"twenty":-10.277026,"median":-9.57298,"eighty":-8.727691,"marketCap":374022017},{"date":"2024-10-11","current":-10.566121,"twenty":-10.505561,"median":-9.728296,"eighty":-8.794895,"marketCap":343663087},{"date":"2024-10-18","current":-9.543111,"twenty":-10.587029,"median":-9.800025,"eighty":-8.869568,"marketCap":310389700},{"date":"2024-10-25","current":-7.586699,"twenty":-10.505561,"median":-9.574426,"eighty":-8.581333,"marketCap":246757383},{"date":"2024-10-31","current":-7.579232,"twenty":-10.485041,"median":-9.464706,"eighty":-8.226879,"marketCap":246514511},{"date":"2024-11-08","current":-10.424244,"twenty":-10.485041,"median":-9.3863,"eighty":-8.226879,"marketCap":339048530},{"date":"2024-11-15","current":-4.166082,"twenty":-10.46953,"median":-9.378833,"eighty":-8.149728,"marketCap":255280837},{"date":"2024-11-22","current":-4.310765,"twenty":-10.439178,"median":-9.30416,"eighty":-7.969021,"marketCap":264146442},{"date":"2024-11-29","current":-5.065892,"twenty":-10.411264,"median":-9.046867,"eighty":-7.81669,"marketCap":310417611},{"date":"2024-12-06","current":-4.598149,"twenty":-10.334409,"median":-8.970887,"eighty":-7.365669,"marketCap":281756204},{"date":"2024-12-13","current":-4.233469,"twenty":-10.223229,"median":-8.939273,"eighty":-5.058757,"marketCap":259410023},{"date":"2024-12-20","current":-3.963922,"twenty":-10.173512,"median":-8.885996,"eighty":-4.852633,"marketCap":242893280},{"date":"2024-12-27","current":-4.17401,"twenty":-10.150694,"median":-8.781454,"eighty":-4.667914,"marketCap":255766623},{"date":"2025-01-03","current":-3.95203,"twenty":-10.131774,"median":-8.549971,"eighty":-4.598149,"marketCap":242164600},{"date":"2025-01-10","current":-4.066984,"twenty":-10.131774,"median":-8.396892,"eighty":-4.398368,"marketCap":249208505},{"date":"2025-01-17","current":-2.687539,"twenty":-10.07439,"median":-8.17661,"eighty":-4.337719,"marketCap":164681643},{"date":"2025-01-24","current":-2.477451,"twenty":-10.049285,"median":-8.109405,"eighty":-4.224748,"marketCap":151808300},{"date":"2025-01-31","current":-2.140518,"twenty":-10.011532,"median":-8.012331,"eighty":-4.193829,"marketCap":131162371},{"date":"2025-02-07","current":-1.823404,"twenty":-9.967928,"median":-7.881014,"eighty":-4.108209,"marketCap":111730908},{"date":"2025-02-14","current":-1.589533,"twenty":-9.948785,"median":-7.698708,"eighty":-3.978192,"marketCap":97400205},{"date":"2025-02-21","current":-1.502326,"twenty":-9.945199,"median":-7.508293,"eighty":-3.804572,"marketCap":92056553},{"date":"2025-02-28","current":-1.478543,"twenty":-9.911206,"median":-5.18038,"eighty":-2.77871,"marketCap":90599193},{"date":"2025-03-07","current":-2.0216,"twenty":-9.837683,"median":-5.059946,"eighty":-2.521847,"marketCap":123875572},{"date":"2025-03-14","current":-2.219796,"twenty":-9.795827,"median":-4.998506,"eighty":-2.343471,"marketCap":136020236},{"date":"2025-03-21","current":-1.601424,"twenty":-9.736345,"median":-4.76067,"eighty":-2.165887,"marketCap":98128885},{"date":"2025-03-28","current":-1.319282,"twenty":-9.624289,"median":-4.665536,"eighty":-2.054897,"marketCap":86245441},{"date":"2025-04-04","current":-0.946604,"twenty":-9.574715,"median":-4.606077,"eighty":-1.965312,"marketCap":61882322},{"date":"2025-04-11","current":-0.685729,"twenty":-9.561032,"median":-4.439593,"eighty":-1.797242,"marketCap":44828138},{"date":"2025-04-17","current":-0.857161,"twenty":-9.511749,"median":-4.37617,"eighty":-1.744126,"marketCap":56035173},{"date":"2025-04-25","current":-0.913063,"twenty":-9.383313,"median":-4.344458,"eighty":-1.606181,"marketCap":59689641},{"date":"2025-05-02","current":-0.883248,"twenty":-9.365642,"median":-4.233469,"eighty":-1.560992,"marketCap":57740592},{"date":"2025-05-09","current":-0.740531,"twenty":-9.335033,"median":-4.213649,"eighty":-1.495984,"marketCap":53111599},{"date":"2025-05-16","current":-0.723546,"twenty":-9.26085,"median":-4.193829,"eighty":-1.480232,"marketCap":51893443},{"date":"2025-05-23","current":-0.672592,"twenty":-9.079462,"median":-4.170046,"eighty":-1.376675,"marketCap":48238975},{"date":"2025-05-30","current":-0.696371,"twenty":-9.046867,"median":-4.104641,"eighty":-1.177664,"marketCap":49944393},{"date":"2025-06-06","current":-0.665798,"twenty":-9.028935,"median":-3.995633,"eighty":-0.946604,"marketCap":47751713},{"date":"2025-06-13","current":-0.696371,"twenty":-8.975602,"median":-3.957976,"eighty":-0.913063,"marketCap":49944393},{"date":"2025-06-20","current":-0.570684,"twenty":-8.968058,"median":-3.829149,"eighty":-0.909336,"marketCap":40930039},{"date":"2025-06-27","current":-0.533318,"twenty":-8.961769,"median":-2.822312,"eighty":-0.881757,"marketCap":38250096},{"date":"2025-07-03","current":-0.546906,"twenty":-8.947831,"median":-2.762854,"eighty":-0.830328,"marketCap":39224621},{"date":"2025-07-11","current":-0.60805,"twenty":-8.911787,"median":-2.592405,"eighty":-0.73948,"marketCap":43609983},{"date":"2025-07-18","current":-0.879805,"twenty":-8.888983,"median":-2.477451,"eighty":-0.736237,"marketCap":63100478},{"date":"2025-07-25","current":-1.168544,"twenty":-8.885996,"median":-2.34466,"eighty":-0.73948,"marketCap":83809129},{"date":"2025-08-01","current":-1.019079,"twenty":-8.836712,"median":-2.219796,"eighty":-0.740531,"marketCap":73089357},{"date":"2025-08-08","current":-0.856075,"twenty":-8.776974,"median":-2.136554,"eighty":-0.74119,"marketCap":64318634},{"date":"2025-08-15","current":-0.877783,"twenty":-8.664966,"median":-2.104843,"eighty":-0.766227,"marketCap":65949557},{"date":"2025-08-22","current":-0.90054,"twenty":-8.539516,"median":-2.017636,"eighty":-0.794855,"marketCap":67659360},{"date":"2025-08-29","current":-1.027331,"twenty":-8.461857,"median":-1.938358,"eighty":-0.806285,"marketCap":77185407},{"date":"2025-09-05","current":-1.011075,"twenty":-8.405106,"median":-1.906646,"eighty":-0.809828,"marketCap":75964119},{"date":"2025-09-12","current":-0.864778,"twenty":-8.31765,"median":-1.769891,"eighty":-0.816568,"marketCap":64972526},{"date":"2025-09-19","current":-0.773749,"twenty":-8.226879,"median":-1.740162,"eighty":-0.790778,"marketCap":58133313},{"date":"2025-09-26","current":-0.978565,"twenty":-8.17661,"median":-1.635118,"eighty":-0.805192,"marketCap":73521543},{"date":"2025-10-03","current":-0.959059,"twenty":-8.149728,"median":-1.601424,"eighty":-0.809828,"marketCap":72055997},{"date":"2025-10-10","current":-0.975314,"twenty":-8.101082,"median":-1.571695,"eighty":-0.816568,"marketCap":73277286},{"date":"2025-10-17","current":-0.90054,"twenty":-8.061078,"median":-1.530074,"eighty":-0.825779,"marketCap":67659360},{"date":"2025-10-24","current":-1.573506,"twenty":-8.013824,"median":-1.539983,"eighty":-0.830317,"marketCap":118220688},{"date":"2025-10-31","current":-1.280912,"twenty":-7.969021,"median":-1.537745,"eighty":-0.833281,"marketCap":96237502},{"date":"2025-11-07","current":-1.11836,"twenty":-7.90156,"median":-1.498363,"eighty":-0.837688,"marketCap":84024621},{"date":"2025-11-14","current":-1.102105,"twenty":-7.858868,"median":-1.490435,"eighty":-0.847643,"marketCap":82803333},{"date":"2025-11-21","current":-0.982565,"twenty":-7.819676,"median":-1.476561,"eighty":-0.856509,"marketCap":77807345},{"date":"2025-11-28","current":-1.16544,"twenty":-7.765913,"median":-1.457948,"eighty":-0.858684,"marketCap":92288839},{"date":"2025-12-05","current":-1.170089,"twenty":-7.585206,"median":-1.427209,"eighty":-0.865066,"marketCap":92657012},{"date":"2025-12-12","current":-0.973266,"twenty":-7.550856,"median":-1.356118,"eighty":-0.866579,"marketCap":77070998},{"date":"2025-12-19","current":-1.441302,"twenty":-7.413459,"median":-1.35655,"eighty":-0.869582,"marketCap":114133803},{"date":"2025-12-26","current":-1.332817,"twenty":-7.317879,"median":-1.35655,"eighty":-0.875795,"marketCap":105543087},{"date":"2026-01-02","current":-1.329717,"twenty":-5.60788,"median":-1.355686,"eighty":-0.876285,"marketCap":105297638},{"date":"2026-01-09","current":-1.419605,"twenty":-5.08879,"median":-1.356118,"eighty":-0.877508,"marketCap":112415660},{"date":"2026-01-16","current":-1.38241,"twenty":-5.065892,"median":-1.373111,"eighty":-0.877783,"marketCap":109470271},{"date":"2026-01-23","current":-1.534289,"twenty":-5.058757,"median":-1.38241,"eighty":-0.877783,"marketCap":121497274},{"date":"2026-01-30","current":-1.286323,"twenty":-5.046865,"median":-1.38396,"eighty":-0.878996,"marketCap":101861351},{"date":"2026-02-06","current":-1.199535,"twenty":-5.015947,"median":-1.373111,"eighty":-0.880542,"marketCap":94988778},{"date":"2026-02-13","current":-1.23673,"twenty":-4.922398,"median":-1.361731,"eighty":-0.882362,"marketCap":97934166},{"date":"2026-02-20","current":-1.404107,"twenty":-4.858976,"median":-1.356118,"eighty":-0.88623,"marketCap":111188415},{"date":"2026-02-27","current":-1.689268,"twenty":-4.776526,"median":-1.370012,"eighty":-0.890736,"marketCap":133769726},{"date":"2026-03-06","current":-1.779155,"twenty":-4.679806,"median":-1.38241,"eighty":-0.892087,"marketCap":140887748},{"date":"2026-03-13","current":-1.989358,"twenty":-4.672671,"median":-1.404107,"eighty":-0.894194,"marketCap":166837536},{"date":"2026-03-20","current":-1.626853,"twenty":-4.654437,"median":-1.418531,"eighty":-0.895573,"marketCap":136436029},{"date":"2026-03-27","current":-1.520754,"twenty":-4.628275,"median":-1.425804,"eighty":-0.898589,"marketCap":127538027},{"date":"2026-04-02","current":-1.989358,"twenty":-4.610834,"median":-1.432003,"eighty":-0.90054,"marketCap":166837536},{"date":"2026-04-10","current":-2.004094,"twenty":-4.574366,"median":-1.4506,"eighty":-0.90119,"marketCap":168073369},{"date":"2026-04-17","current":-3.569056,"twenty":-4.471304,"median":-1.457173,"eighty":-0.904441,"marketCap":299318897},{"date":"2026-04-24","current":-3.330333,"twenty":-4.432458,"median":-1.470747,"eighty":-0.907501,"marketCap":279298393},{"date":"2026-05-01","current":-3.01793,"twenty":-4.398368,"median":-1.476546,"eighty":-0.909336,"marketCap":253098721},{"date":"2026-05-08","current":-3.689891,"twenty":-4.369828,"median":-1.481596,"eighty":-0.910081,"marketCap":309452733},{"date":"2026-05-15","current":-3.031745,"twenty":-4.344458,"median":-1.487795,"eighty":-0.913063,"marketCap":263974056},{"date":"2026-05-22","current":-4.458708,"twenty":-4.432458,"median":-1.494399,"eighty":-0.913063,"marketCap":388219702},{"date":"2026-05-29","current":-4.246654,"twenty":-4.403917,"median":-1.50281,"eighty":-0.913063,"marketCap":369756186},{"date":"2026-06-05","current":-4.285717,"twenty":-4.403917,"median":-1.512592,"eighty":-0.913063,"marketCap":373157360},{"date":"2026-06-12","current":-4.464288,"twenty":-4.403917,"median":-1.532182,"eighty":-0.913063,"marketCap":388705584},{"date":"2026-06-18","current":-5.546878,"twenty":-4.459824,"median":-1.539565,"eighty":-0.913448,"marketCap":482966688},{"date":"2026-06-26","current":-4.927458,"twenty":-4.618762,"median":-1.553857,"eighty":-0.916145,"marketCap":429033788},{"date":"2026-07-02","current":-5.468753,"twenty":-4.679014,"median":-1.559086,"eighty":-0.919028,"marketCap":476164340},{"date":"2026-07-10","current":-5.251119,"twenty":-4.852633,"median":-1.578076,"eighty":-0.922185,"marketCap":457214943},{"date":"2026-07-17","current":-5.044646,"twenty":-4.98936,"median":-1.593497,"eighty":-0.929149,"marketCap":439237309},{"date":"2026-07-24","current":-5.652905,"twenty":-5.058757,"median":-1.601424,"eighty":-0.93305,"marketCap":492198445},{"date":"2026-07-31","current":-5.820316,"twenty":-5.116075,"median":-1.607696,"eighty":-0.93435,"marketCap":506774905},{"date":"2026-08-07","current":-6.195168,"twenty":-5.189342,"median":-1.626853,"eighty":-0.936301,"marketCap":562651332},{"date":"2026-08-14","current":-6.082936,"twenty":-5.239958,"median":-1.667148,"eighty":-0.936301,"marketCap":552458367},{"date":"2026-08-21","current":-5.996806,"twenty":-5.366075,"median":-1.692595,"eighty":-0.938902,"marketCap":544635947}],"updateTime":1787506128884},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARTV\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618513207","title":"Artiva Biotherapeutics, Inc. (ARTV) Receives a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2618513207","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618513207?lang=en_us&edition=fundamental","pubTime":"2026-03-12 21:20","pubTimestamp":1773321609,"startTime":"0","endTime":"0","summary":"Jefferies analyst maintained a Buy rating on Artiva Biotherapeutics, Inc. today and set a price target of $19.00. In addition to Jefferies, Artiva ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/artiva-biotherapeutics-inc-artv-receives-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/artiva-biotherapeutics-inc-artv-receives-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618949683","title":"Artiva Biotherapeutics Price Target Maintained With a $18.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2618949683","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618949683?lang=en_us&edition=fundamental","pubTime":"2026-03-11 18:59","pubTimestamp":1773226740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARTV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 11, 2026 06:59 ET (10:59 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618969883","title":"Artiva Biotherapeutics Q4 EPS $(0.84) Misses $(0.83) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2618969883","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618969883?lang=en_us&edition=fundamental","pubTime":"2026-03-11 04:10","pubTimestamp":1773173429,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics (NASDAQ:ARTV) reported quarterly losses of $(0.84) per share which missed the analyst consensus estimate of $(0.83) by 1.45 percent. This is a 27.27 percent decrease over losses of $(0.66) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51173483/artiva-biotherapeutics-q4-eps-0-84-misses-0-83-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Artiva Biotherapeutics Q4 EPS $(0.84) Misses $(0.83) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618966229","title":"Artiva Biotherapeutics FY2025 net loss rises 28% to USD 83.87 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2618966229","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618966229?lang=en_us&edition=fundamental","pubTime":"2026-03-11 04:07","pubTimestamp":1773173240,"startTime":"0","endTime":"0","summary":"Artiva reported a FY 2025 net loss of USD 83.87 million, widening 28% from the prior year. FY 2025 research and development expenses rose 38% to USD 69.54 million, while general and administrative expenses increased 18% to USD 20.27 million. Other income, net was USD 5.95 million in FY 2025, up more than doubled from the prior year. Artiva ended FY 2025 with cash, cash equivalents and investments of USD 108.01 million, which it expects will fund operations into Q2 2027. Management said initial clinical response data for AlloNK in refractory rheumatoid arthritis are expected in H1 2026, alongside an FDA interaction on a potential pivotal trial design.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nNDL51xkqZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4585","IE00BKPKM429.USD","BK4588","BK4139","SG9999014021.USD","IE00B64PRP62.GBP","ARTV","LU2210149790.SGD","LU2210150020.SGD","SG9999014013.SGD","SG9999014039.USD","IE00BGHQF748.EUR","LU2095319765.USD","SG9999014005.SGD","LU0314104364.USD","BK4112","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618966465","title":"Press Release: Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2618966465","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618966465?lang=en_us&edition=fundamental","pubTime":"2026-03-11 04:05","pubTimestamp":1773173100,"startTime":"0","endTime":"0","summary":"Initial clinical response data for AlloNK in refractory rheumatoid arthritis  expected in first half of 2026. U.S. Food and Drug Administration  interaction to discuss potential pivotal trial design for AlloNK expected in first half of 2026. Strengthened board and executive leadership with deep immunology, commercial and financial expertise. Robust balance sheet with cash, cash equivalents and investments of $108.0 million as of December 31, 2025, expected to fund operations into Q2 2027. Dr. Aslan continued, \"In 2026, our focus is to advance AlloNK from an early clinical program in the deep B-cell depletion space to what could become the first therapy in this class to initiate a registrational trial in RA, the autoimmune disease with the largest refractory population. We look forward to sharing initial clinical response data and engaging with the FDA on a potential pivotal trial design in refractory RA in the first half of 2026.\". -- Prioritized refractory RA as lead indication: Recei","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","R","SLE","BK4022","BK4232","RA","LU0963586101.USD","IE0031619046.USD","BK4187","BK4139","BK4006","IE00B7SZL793.SGD","CRS","IE00B66KJ199.SGD","IE00B19Z4B17.USD","BK4077","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614726617","title":"Artiva Biotherapeutics Files Initial Beneficial Ownership Statement for CFO Huston Thad Allen","url":"https://stock-news.laohu8.com/highlight/detail?id=2614726617","media":"Reuters","labels":["executive","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614726617?lang=en_us&edition=fundamental","pubTime":"2026-02-25 06:16","pubTimestamp":1771971384,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics, Inc. filed an initial statement of beneficial ownership naming Huston Thad Allen, Chief Financial Officer, as the reporting person. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 24, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL65phgZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Artiva Biotherapeutics Files Initial Beneficial Ownership Statement for CFO Huston Thad Allen","news_tag":"executive,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613371117","title":"Artiva Biotherapeutics Awards CFO Thad Huston 220,000 RSUs Under 2025 Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2613371117","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613371117?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:03","pubTimestamp":1771938220,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics said its board approved an employment inducement grant for newly appointed CFO Thad Huston consisting of 220,000 restricted stock units under the company’s 2025 Inducement Plan. The award is expected to be granted after an S-8 registration statement is filed, and will vest over four years, with 25% vesting on Feb. 15, 2027 and the remainder vesting quarterly thereafter, subject to continued employment.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL3CBMZx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","LU0314104364.USD","SG9999014021.USD","SG9999014039.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU2095319765.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","ARTV","SG9999014013.SGD","SG9999014005.SGD","BK4585","BK4588","LU2210149790.SGD","BK4139","IE00BKPKM429.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613927711","title":"Press Release: Artiva Biotherapeutics Announces Appointment of Thad Huston as Chief Financial Officer and Award of Inducement Grant","url":"https://stock-news.laohu8.com/highlight/detail?id=2613927711","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613927711?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:00","pubTimestamp":1771938000,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Feb. 24, 2026  -- Artiva Biotherapeutics, Inc.  , a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers, today announced the appointment of Thad Huston as Chief Financial Officer. Mr. Huston brings proven expertise in capital allocation, operational execution and global commercialization to support Artiva as it advances AlloNK in autoimmune diseases and continues building an organization positioned for long-term value creation.\"We are delighted to welcome Thad to Artiva as he brings strong late-stage development and commercial expertise to our leadership team,\" said Fred Aslan, M.D., president and chief executive officer of Artiva Biotherapeutics. \"AlloNK has the potential to deliver deep B-cell depletion with biologics-like convenience. This is an important time for Artiva as we prepare to receive feedback from the FDA on a potential pivotal trial and sha","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","ARTV","BK4139","R","BK4232"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":88,"code":"91000000","status":"200"}]}}